Total Intravenous Versus Inhalational Anesthesia in High-Grade Glioma Surgery: A Systematic Review and Meta-Analysis.

Plamen Penchev, Boris Tablov, Mariano Gallo Ruelas, Daniela Milanova-Ilieva, Lyubomir Gaydarski, Nikolay Yordanov, Eduardo Alonso, Danna Espinoza, Petar-Preslav Petrov, Ivelina Lukanova, Pavel Stanchev, Julian Dichev, Ivana Korentova, Nikolai Ramadanov

Journal: Medicina (Kaunas, Lithuania) 2025;61(8):

PMID: 40870507

Abstract

: High-grade gliomas (HGGs) are aggressive primary brain tumors with a poor prognosis despite multimodal treatment. The anesthetic technique used during surgery may influence tumor progression and survival, but its role in HGGs remains unclear. This meta-analysis evaluated the effect of total intravenous anesthesia (TIVA) versus inhalational anesthesia (INHA) on overall survival (OS) and progression-free survival (PFS) in HGG patients. : A systematic search was conducted in PubMed, Scopus, and Cochrane databases for studies assessing the impact of TIVA versus INHA on OS and PFS in HGG patients. Statistical analysis was performed using R version 4.3.1. Heterogeneity across studies was quantified using the Cochrane Q test alongside the I statistic. A random-effects model was employed to derive the pooled hazard ratios (HRs). : A total of five studies involving 827 participants (mean age 58 years, mean females 38%) were included, of whom 406 (49%) received TIVA. No statistically significant differences were observed in OS (HR 0.77; 95% CI [0.58-1.02]; = 0.07; I = 67%) or PFS (HR 0.88; 95% CI [0.70-1.10]; = 0.27; I = 51%) between the groups. A subgroup analysis revealed that TIVA was associated with improved OS in patients with grade IV tumors (HR 0.70; 95% CI [0.51-0.96]; = 0.03), while no significant effect was observed in the mixed grade III-IV subgroup. However, the test for subgroup differences was not statistically significant ( = 0.0669), and this finding should be interpreted with caution. No significant differences were observed in median OS or PFS, or in single-arm meta-analyses. : This meta-analysis found no statistically significant differences in overall or progression-free survival between TIVA and INHA in patients undergoing surgery for HGGs. Although a subgroup analysis suggested a possible survival advantage of TIVA in grade IV tumors, the lack of a statistically significant subgroup difference test limits the strength of this finding. Further investigation is needed to determine whether anesthetic technique influences outcomes in this subgroup.

Address: Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.; Department of Anesthesiology and Intensive Care, Multiprofile Hospital for Active Treatment "Life Hospital", 8008 Burgas, Bulgaria.; Instituto de Investigación Nutricional (IIN), Lima 15024, Peru.; Department of Pediatrics, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.; Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria.; Department of Neurointensive Care, Multiprofile Hospital for Active Treatment in Neurology and Psychiatry "St. Naum", 1113 Sofia, Bulgaria.; Hospital de Especialidades Teodoro Maldonado Carbo, Universidad Católica de Santiago de Guayaquil, Guayaquil 090615, Ecuador.; Department of Anatomy, Histology and Embryology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.; Faculty of Medicine, Medical University, 1000 Sofia, Bulgaria.; Clinic of Endocrinology and Metabolic Diseases, St. George University Hospital, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.; Faculty of Medicine, Trakia University, 6000 Stara Zagora, Bulgaria.; Center of Orthopaedics and Traumatology, Brandenburg Medical School, University Hospital Brandenburg, 14770 Brandenburg an der Havel, Germany.; Faculty of Health Science Brandenburg, Brandenburg Medical School Theodor Fontane, 16816 Brandenburg an der Havel, Germany.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.